Overview
News
Technologies
Salaries
Products
People
Growth
Financials

Overview

Join SynBioBeta, the global community of biological engineers, entrepreneurs, investors, and innovators working to make biology easier to engineer.

News

News synbiobeta.com 2 years ago
Heart Failure May Soon Be Reversible with New Gene Therapy
A novel therapy that replenishes cBIN1 protein in cardiac cells may hold the key to reversing heart failure's relentless progression
Read more
Report
News synbiobeta.com 2 years ago
How Cultivated Meat Carved Out Its Plate in History
Discover how cultivated meat evolved from a futuristic concept to an emerging reality poised to transform our dinner tables
Read more
Report
Award businesswire 2 years ago
Nobel Laureate Thomas Südhof and bit.bio CEO Mark Kotter to Lead Fireside Chat on Programming Human Cells at SynBioBeta
bit.bio, the company coding human cells for novel cures, and a pioneer in the field of synthetic biology, today announces it will participate in an engaging ...
Read more
Report
News synbiobeta.com 3 years ago
Tiny Cellular Tattoos Emerge as Nanoscale Health Sentinels
Cutting-edge Breakthrough Enables Live Cell Tracking through Innovative Tattoo-like Arrays
Read more
Report
Pro access
Upgrade to see all 19 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.